Big Pharma’s ‘Pay for Delay’ Eyed
Supreme Court weighs incentives paid to makers of generic drugs
March 25, 2013
WASHINGTON — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name......
No comments posted for this article.
Post a Comment